Most Recent Articles by Tara Haelle, MS
The reasons for physicians' discomfort with conversations about dying are as much cultural, social, and systemic as they are personal.
The potential consequences of providing cosmetic treatment to a patient with BDD can extend beyond ethical concerns.
FDA Approval of Medication With a Digital Monitoring System: Major Breakthrough or "Brave New World"?Jul 23, 2018
Abilify MyCite adds a digital sensor to the medication aripiprazole. The sensor, an ingestible event marker, is activated by contact with stomach acids and transmits a signal to a skin patch the patient wears, which then transmits to an app.
While researchers continue learning about specific interactions between poor sleep and psychotic symptoms, clinicians should be incorporating more comprehensive questions about sleep into their assessment of patients.
Parents using intervention strategies in addition to the interventionist working directly with the child can be very beneficial, as an interventionist only gets to see a child for a few hours a week.
More Articles by Tara Haelle, MS
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Correctional Psychiatry: Challenges and Rewards
- Link Identified Between Cured Meat and Mania in Bipolar Disorder
- First-Episode Delusional Disorder vs Schizophrenia: Assessment of Outcomes
- Physician Perspectives: Examining the Intersections of White Privilege and Racism in Medicine
- Prevalence of Schizophrenia in Individuals With Type 2 Diabetes
- Anatomical Patterns Present in Childhood ADHD May Predict Phenotypic Variation
- History of ADHD Associated With Increased Risk for Basal Ganglia and Cerebellum Disorders
- Suicide Attempts Associated With Sleep and Circadian Rhythm Disturbances in Bipolar Disorder
- Retirement Associated With Increased Risk for Depressive Symptoms
- Probiotics, Depression, and the Role of Inflammation